Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Changes in Stockholders' Deficit

v3.25.3
Consolidated Statements of Changes in Stockholders' Deficit - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance at Sep. 30, 2023 $ 22 $ 110,017,751 $ (110,243,753) $ (225,980)
Balance, shares at Sep. 30, 2023 218,786      
Sale of common stock, net of issuance costs $ 17 3,976,365 3,976,382
Sale of common stock, net of issuance costs, shares   167,987      
Retirement of shares in connection with reverse stock split
Retirement of shares in connection with reverse stock split, shares   (190)      
Issuance of common stock on vesting of restricted stock units and restricted stock awards
Issuance of common stock on vesting of restricted stock units and restricted stock awards, shares   976      
Net share settlement of warrants $ 9 (9)
Net share settlement of warrants, shares   94,288      
Exercise and modification of warrants, net of issuance costs $ 17 2,969,884 2,969,901
Exercise and modification of warrants, net of issuance costs, shares   168,437      
Share-based compensation 231,190 231,190
Net loss (7,437,232) (7,437,232)
Ending balance at Sep. 30, 2024 $ 65 117,195,181 (117,680,985) (485,739)
Balance, shares at Sep. 30, 2024 650,284      
Sale of common stock, net of issuance costs $ 120 7,806,377 7,806,497
Sale of common stock, net of issuance costs, shares   1,203,520      
Retirement of shares in connection with reverse stock split
Retirement of shares in connection with reverse stock split, shares   (373)      
Issuance of common stock on vesting of restricted stock units and restricted stock awards $ 2 (2)
Issuance of common stock on vesting of restricted stock units and restricted stock awards, shares   17,152      
Net share settlement of warrants
Net share settlement of warrants, shares   1,209      
Share-based compensation 199,595 199,595
Net loss (16,011,487) (16,011,487)
Shares released from abeyance $ 19 (19)
Shares released from abeyance, shares   187,500      
Sale of warrants in connection with convertible notes, net of issuance costs 578,874 578,874
Exercise of warrants $ 502 11,199,337 11,199,839
Exercise of warrants, shares   5,018,060      
Sale of preferred stock, net of issuance costs $ 1 5,499,999 5,500,000
Sale of preferred stock, net of issuance costs, shares 5,500        
Conversion of convertible notes into preferred stock 2,000,000 2,000,000
Conversion of convertible notes into preferred stock, shares 2,000        
Ending balance at Sep. 30, 2025 $ 1 $ 708 $ 144,479,342 $ (133,692,472) $ 10,787,579
Balance, shares at Sep. 30, 2025 7,500 7,077,352